Research in the Melamed lab seeks to understand how genetics, dietary factors and gut microbiome contribute toward the risk of development and progression of multiple sclerosis, neuromyelitis optica and other autoimmune neurological conditions in males and females. Our work utilizes a broad range of approaches, ranging from molecular biology and immunology techniques to gene expression profiling in the central nervous system and immune system, microbiome sequencing, animal behavioral studies, and patient studies. The goal of our basic science studies is to advance the individualized care for men and women living with autoimmune neurological conditions.
There is currently a lot of uncertainty about short term and long term health outcomes of COVID-19. In collaboration with scientists and clinicians at UT Austin, Dell Medical School and Seton hospitals, we are conducting a prospective longitudinal research study to understand COVID-19 immune responses in people across age, gender, ethnicity, and disease severity. Dell Medical School and UT Austin are part of a multi-center COVID-19 research initiative, funded by the NIH, and our lab is also working with a local medical diagnostics company, Babson Diagnostics. Participants will be part of a national effort to understand immune mechanisms of COVID-19 and long-term COVID-19 health outcomes, will receive a modest compensation, and may learn about their SARS-CoV-2 antibody status.
If you would like to learn more about our COVID-19 research and find out if you could participate, please contact us.